|
|
||||||||
Technical Innovation |
1
Division of Cardiovascular and Interventional Radiology, Stanford University
Medical Center, 300 Pasteur Dr., Ste. H3600, Stanford, CA 94305-5642.
2
Present address: Division of Vascular and Interventional Radiology,
Rush-Presbyterian-St. Luke's Medical Center, 1725 W. Harrison St., Ste. 400,
Chicago, IL 60612.
3
Department of General Surgery, Stanford University Medical Center, Stanford,
CA 94305-5655.
Received December 17, 1999;
accepted after revision February 2, 2000.
Address correspondence to D. Y. Sze.
Introduction
|
|
|---|
|
|
|---|
|
|
On transfer to our institution, the patient was acidotic and hemodynamically unstable. Imaging to assess the effect of urokinase was not pursued. The patient underwent exploratory laparotomy, and 1.4 m of necrotic jejunum was resected. A small amount of thrombus was successfully expressed from the divided branches of the superior mesenteric vein. The liver did not appear cirrhotic, and no portosystemic collateral vessels were identified. A primary duodenoileal anastomosis was performed, and IV heparin was restarted. Pathologic examination of the resected specimen confirmed transmural infarction, vascular congestion, and extravasation of RBC.
Although improved, the patient remained acidotic and produced copious ascites. Because of this evidence of persistent ischemia, mechanical thrombolysis was proposed to improve splanchnic venous outflow. Because the transhepatic route is associated with a greater risk of hemorrhage, particularly in the presence of ascites and anticoagulation, a transjugular approach was used [3]. With the patient still under general anesthesia, a wedged carbon dioxide portogram was obtained, opacifying only the left portal vein. A Rosch-Uchida set (Cook, Bloomington, IN) was used to gain access to the left portal vein, and the tract was dilated to 6 mm in diameter with an angioplasty balloon (Marshall; Boston Scientific, Watertown, MA). A 10-French sheath (Cook) was passed through the tract and into the portal vein. The portosystemic gradient could not be measured because of the extensive thrombosis.
Over a 0.018-inch guidewire (Hi-Torque Flex-T; Mallinckrodt, St. Louis, MO), an AngioJet device (AV-60 catheter; Possis Medical, Minneapolis, MN) was used to aspirate as much thrombus as possible from the main portal vein. To remove residual mural thrombus, a 12 x 60 mm Wallstent (Boston Scientific) was then deployed in the tract and portal vein to provide a conduit into which the residual thrombus was swept with an angioplasty balloon.
Venography of the superior mesenteric and splenic veins confirmed thrombosis in both veins, with poorly formed collateral drainage (Fig. 1C). The AngioJet device was reintroduced through a 6-French angled guide-catheter (Cordis/Johnson & Johnson, Miami, FL), and thrombus in these large-caliber veins was aspirated using a helical sweeping pattern. In addition, the device was used in four tributaries of the superior mesenteric vein. A total of 1000 mL of effluent was collected. Antegrade flow was reestablished in the splenic vein, main trunk of the superior mesenteric vein, main portal vein, and left portal vein (Fig. 1D). The portosystemic gradient was 5 mm Hg after the thrombolysis, and the stent was intentionally left undilated to encourage flow into the left portal vein.
|
|
|
|
|---|
|
|
|
|---|
Bowel infarction obligates surgical resection, but ischemia may respond to percutaneous therapies. IV thrombolysis for portal thrombosis was first reported in 1971, followed by reports of catheter-directed thrombolysis using a variety of access routes [3]. Infusion catheters have been introduced into the superior mesenteric vein at the time of bowel resection [4] via a percutaneous transhepatic route [5] or via a transjugular route [6]. An alternative route of treatment is via the superior mesenteric artery. Although a few successful case reports have appeared [7], lysis of any venous thrombus by infusion into the feeding artery is unpredictable because of preferential flow into collaterals.
A major obstacle to the use of thrombolytic agents is the risk of gastrointestinal hemorrhage. In a review of 53 patients with acute thrombosis, 28% presented with upper and 23% with lower gastrointestinal bleeding [2]. Whether administered IV or locally, thrombolytics could be catastrophic in these patients. In the case presented here, the referring physicians were forced to discontinue thrombolytic infusion because of life-threatening hemorrhage. In high-risk patients, a mechanical method of recanalization is especially attractive. Mechanical devices approved for dialysis access are potentially effective, but only in vessels large enough to accommodate them. Pharmacologic thrombolysis may still play a role in treatment of smaller vessels.
We have also used the AngioJet successfully in four patients with occluded transjugular intrahepatic portosystemic shunts whose thromboses propagated into portal and mesenteric veins, including two patients who were actively bleeding [8]. One other successful case of mechanical thrombolysis using the AngioJet, followed by catheter-directed venous thrombolysis, was reported in a patient who then required liver transplantation [3]. Limited effect of another mechanical thrombolysis device (amplatz Thrombectomy Device; Microvena, White Bear Lake, MN) has also been reported [8, 9]. In all these cases, including the one currently described, mechanical thrombolysis was incompletely successful, and the use of balloons and pharmacologic thrombolytics provided additional benefit.
Long-term survival of patients with mesenteric venous thrombosis is disappointing. In patients with acute mesenteric venous thrombosis, the 3-year survival rate is only 36% [2]. In part, this reflects the high rate of recurrence in this population, ranging from 14% to 71% [1]. Mesenteric venous thrombosis may be the sentinel and only presentation of a hypercoagulable state. Adequate surgical resection and anticoagulation clearly increase disease-free survival, but most thrombotic disorders are not currently reversible.
|
|
|---|
This article has been cited by other articles:
![]() |
A. W. James, C. Rabl, A. C. Westphalen, P. F. Fogarty, A. M. Posselt, and G. M. Campos Portomesenteric Venous Thrombosis After Laparoscopic Surgery: A Systematic Literature Review Arch Surg, June 1, 2009; 144(6): 520 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Warshauer, J. K. T. Lee, M. A. Mauro, and G. C. White II Superior Mesenteric Vein Thrombosis with Radiologically Occult Cause: A Retrospective Study of 43 Cases Am. J. Roentgenol., October 1, 2001; 177(4): 837 - 841. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |